fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd

Updated on May 18, 2019

Stock/Share Code - SUNPHARMA

Sun Pharmaceuticals Industries is in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

Below is the details of SUNPHARMA Sun Pharmaceuticals Industries Ltd

Market Cap₹106,806 Cr.
Current Price ₹412.95 as on 23 May 19
52 Week High / Low Price₹678.8 / ₹375.4
Face Value₹1
Stock P/E134.45
Book Value₹77.62
Dividend Yield0.45 %
ROCE2.54 %
ROE1.55 %
Sales Growth (3yrs)-0.44 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros:
Cons: Stock is trading at 5.73 times its book value Company has a low return on equity of -2.03% for last 3 years.

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Piramal Enterp. ₹2,166.4 8.18 ₹42,817.87 Cr. 1.05 ₹603.98 Cr. 23.03 22.07 3489.08 8.85
2. Sun Pharma.Inds. ₹143.35 22.89 ₹106,806.4 Cr. 0.45 ₹1,461.03 Cr. 310.00 16.34 7740.19 10.41
3. Aurobindo Pharma ₹672.15 17.77 ₹41,719.55 Cr. 0.35 ₹712.22 Cr. 22.97 21.53 5269.67 22.85
4. Cadila Health. ₹250.3 16.48 ₹32,626.67 Cr. 1.10 ₹510.7 Cr. -6.00 9.75 3577.90 18.28
5. Dr Reddy's Labs ₹2,637.3 24.73 ₹43,701.41 Cr. 0.76 ₹500.3 Cr. 65.28 0.80 3864.60 7.75
6. Cipla ₹564.75 32.21 ₹44,680.04 Cr. 0.54 ₹332.2 Cr. -17.06 2.39 4007.54 9.64
7. Strides Pharma ₹415.1 4.39 ₹3,769.14 Cr. 0.47 ₹293.42 Cr. 234.73 6.10 794.50 16.15
8. Sun Pharma.Inds. ₹143.35 134.45 ₹106,806.4 Cr. 0.45 -₹38.68 Cr. -112.06 -6.11 2261.26 2.54

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharmaceuticals Industries Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
Sales1,9251,8002,0331,9502,0151,7951,8242,4082,2832,6082,4732,261
YOY Sales Growth %10.15%-12.14%8.23%2.06%4.66%-0.26%-10.27%23.51%13.31%45.24%35.61%-6.11%
Expenses2,0381,8682,0251,9621,8331,9631,9071,9362,0872,1012,3052,087
Material Cost %35.52%41.01%42.86%44.9%41.14%45.26%49.35%38.74%38.27%31.5%36.12%43.4%
Employee Cost %17.08%20.41%17.52%19.35%19.62%23.06%21.55%16.84%17.81%14.09%15.55%17.3%
Operating Profit-112-688-12182-168-84472196506169175
OPM %-6%-4%0%-1%9%-9%-5%20%9%19%7%8%
Other Income3611262947817-9258923317731-68128
Interest82101711418313065111137151133
Depreciation120105104105107110105120111141131134
Profit before tax47-148191-15390-1,286574321151260-795-65
Tax %-9%-2%2%-4%-7%-0%-1%0%-17%0%-1%41%
Net Profit51-151187-15896-1,288577321176259-806-39
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales2,2433,1523,8622,4863,1084,0162,4322,8298,0287,7197,6847,9249,625
Sales Growth %33.5%40.51%22.51%-35.63%25.03%29.22%-39.43%16.31%183.81%-3.85%-0.46%3.12%%
Expenses1,7172,1782,6891,5571,7832,4271,9192,8918,5878,2087,5707,9378,580
Material Cost %51.62%48.44%49.46%32.8%28.86%26.33%36.85%37.65%43.76%38.78%42.91%44.08%%
Manufacturing Cost %3.41%3.18%3.44%5.72%7.28%7.47%16.03%16.24%13.95%15.67%15.84%15.7%%
Employee Cost %4.29%3.72%3.75%6.87%8.4%7.88%9.66%9.89%18.53%19.13%19.52%20.42%%
Other Cost %17.23%13.76%12.99%17.25%12.84%18.76%16.38%38.42%30.71%32.75%20.24%19.97%%
Operating Profit5269741,1729291,3241,588513-62-559-489114-131,046
OPM %23%31%30%37%43%40%21%-2%-7%-6%1%-0%11%
Other Income17013918591194214237-2,619212445515314-445
Interest953000018551574224388532
Depreciation46565969647686102661464422432518
Profit before tax6411,0521,2959491,4541,726663-2,801-1,559-1,082-17-520-450
Tax %2%4%2%5%5%2%22%-1%5%-0%-36%5%
Net Profit6291,0141,2658991,3841,697517-2,829-1,474-1,088-23-495-409
EPS in Rs3.164.725.884.116.397.852.070.000.000.000.000.00
Dividend Payout %21%21%23%32%26%26%50%-11%-42%-22%-3,677%-97%

Compounded Sales Growth

  • 10 Years:: 9.66%
  • 5 Years:: 26.65%
  • 3 Years:: -0.44%
  • TTM:: 19.68%

Compounded Profit Growth

  • 10 Years:: -10.87%
  • 5 Years:: -8.47%
  • TTM:: 38.89%

Return on Equity

  • 10 Years:: 2.46%
  • 5 Years:: -3.36%
  • 3 Years:: -2.03%
  • TTM:: 1.55%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital98104104104104104104207207241240240240
Preference Capital1.3700000000000
Equity Capital96.7103.56103.56103.56103.56103.56103.56207.12207.12240.66239.93239.93
Reserves2,3514,1045,0485,6146,5777,7757,6857,20122,53121,64920,77319,53018,385
Borrowings1,06810324295140432,4096,8115,8296,0476,8847,046
Other Liabilities6291,1091,0387318821,2191,4234,5598,2866,5486,8137,2709,511
Trade Payables375.97646.48477.79223.53269.66429.07399.18416.331646.661856.32187.892604.952295.56
Total Liabilities4,1465,4196,2136,4787,6149,1389,25514,37637,83534,26633,87233,92435,182
Fixed Assets5896306997417949771,1361,2673,1853,5754,0394,5594,850
Gross Block838.7935.031061.91159.761268.761483.031725.141973.535995.074103.74988.085929.21
Accumulated Depreciation249.41303.64361.04416.16474.37505.73589.35706.362809.8529.08949.451370.68
CWIP323376921962493484801,0917681,100874587
Investments1,0571,9432,6954,0523,6014,4384,3187,01625,87622,37219,33318,35518,286
Other Assets2,4672,8122,7441,5943,0223,4743,4545,6137,6837,5529,39910,13611,459
Inventories333.38389.63486.74570.14618.26640.07868.76918.382189.252132.152308.282135.642405.47
Trade receivables564.871055.44680.03553.29542.62713.48737.53980.151802.821997.812714.72846.963205.77
Cash Equivalents1202.68972.871265.4788.871250.911327.71431.12141.48416.46169.11170.28155.27865.66
Loans n Advances366.14394.13311.42381.74466.2451.11917.782810.941337.131695.331906.622476.5985.76
Total Assets4,1465,4196,2136,4787,6149,1389,25514,37637,83534,26633,87233,92435,182

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity4516261,2626461,2321,339106-2,405149-1,254-1,621-1,184
Profit from operations543.621032.491154.07975.741339.671837.86589.46-2757.9-972.99-316.72-68.05-877.19
Working Capital Changes-77.6-361.2107.53-280.95-32.3-354.25-314.22501.611315.06-585.04-769.35-15.45
Taxes paid-15.46-45.160.89-48.79-73.57-144.43-168.76-148.77-193.48-352.73-783.6-291.42
Cash from Investing Activity-113-743-660-159-1,073-7714565172,6423,6402,3811,406
Fixed Assets Purchased-140.78-99.16-173.99-126.86-245.28-388.24-429.54-434.32-1027.98-563.94-1094.01-733.33
Fixed Assets Sold18.850.214.764.70.533.091.092.0614.8414.459.736.27
Investments purchased-2115.87-3766.55-6294.51-16933.54-12294.31-13465.91-15362.87-19453.87-10360.5-13196.91-17638.87-16806.11
Investments sold1843.142993.435682.8315692.3212634.7213184.4714772.5420191.2712191.2613251.9617650.7816833.51
Cash from Financing Activity-360-6-326-327-312-420-5091,742-2,674-2,368-753-272
Proceeds from Shares0000000074.879.132.480.91
Proceeds from Borrowings22.490.725.8921.040000000
Repayment of Borrowings-90.7900000000000
Interest Paid-8.8-5.38-4.53-0.44-0.59-0.43-0.3-18.24-331.98-364.49-143.56-283.69
Dividends Paid-230.26-1.56-206.96-284.39-284.73-352.37-440.12-517.54-310.48-721.68-239.92-798.14
Net Cash Flow-22-123276160-15314853-145117177-50

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %19%27%27%18%23%25%8%0%-6%-3%-0%3%
Debtor Days92122648164651111268294129131
Inventory Turnover7.528.728.814.705.236.383.223.175.173.573.463.57

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharmaceuticals Industries Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.